# Metabolic Characterization of Space Occupying Lesions of the Brain

> **NCT04233788** · — · RECRUITING · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 55 (estimated)

## Conditions studied

- Brain Tumor
- Glioma
- IDH Mutation

## Interventions

- **DEVICE:** MR-scans using a 3T Prisma and a 7T Terra scanner (Siemens, Erlangen Germany)

## Key facts

- **NCT ID:** NCT04233788
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-09-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2024-11-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04233788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04233788, "Metabolic Characterization of Space Occupying Lesions of the Brain". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04233788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*